Vanguard Group Inc. Has $132.69 Million Holdings in Acadia Healthcare Company, Inc. $ACHC

Vanguard Group Inc. trimmed its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 0.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,350,959 shares of the company’s stock after selling 66,086 shares during the quarter. Vanguard Group Inc. owned 0.10% of Acadia Healthcare worth $132,690,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. EverSource Wealth Advisors LLC increased its holdings in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after buying an additional 497 shares during the period. Bayforest Capital Ltd bought a new position in Acadia Healthcare during the fourth quarter worth about $52,000. Hantz Financial Services Inc. grew its stake in Acadia Healthcare by 501.9% during the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after buying an additional 1,822 shares during the last quarter. GAMMA Investing LLC raised its position in Acadia Healthcare by 124.7% in the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock valued at $69,000 after purchasing an additional 2,698 shares during the last quarter. Finally, Quent Capital LLC bought a new stake in shares of Acadia Healthcare during the third quarter worth $71,000.

Analysts Set New Price Targets

ACHC has been the subject of a number of research analyst reports. Raymond James Financial raised Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price target for the company in a report on Monday, May 4th. Guggenheim boosted their target price on shares of Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. UBS Group increased their price target on shares of Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a research note on Friday, April 17th. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, January 21st. Finally, TD Cowen upped their price target on Acadia Healthcare from $24.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, April 28th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $26.04.

Acadia Healthcare Trading Down 0.7%

Shares of NASDAQ:ACHC opened at $25.01 on Tuesday. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.71 and a current ratio of 1.71. Acadia Healthcare Company, Inc. has a 52-week low of $11.43 and a 52-week high of $30.20. The company has a 50-day simple moving average of $25.05 and a 200 day simple moving average of $19.15. The company has a market capitalization of $2.30 billion, a P/E ratio of -2.04, a price-to-earnings-growth ratio of 8.44 and a beta of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.09. The company had revenue of $828.80 million for the quarter, compared to analyst estimates of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company’s revenue was up 7.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.40 earnings per share. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 1.49 earnings per share for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.